Kyverna Therapeutics Aims for FDA Approval of Innovative Cell Therapy
Kyverna Therapeutics is preparing to submit a novel cell therapy for FDA approval, which has shown potential in enhancing mobility for patients with stiff person syndrome during late-stage trials.
Editorial Staff 18 days ago